Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets... Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers. Show more
NEWTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic...
Actively enrolling subjects in ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimerโs disease Dosed the first subject in a Phase 1 study to support...
NEWTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (โAcumenโ or the โCompanyโ), a clinical-stage biopharmaceutical company developing a novel...
NEWTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble...
NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -4.6875 | 2.56 | 2.66 | 2.36 | 200434 | 2.48727854 | CS |
4 | -0.51 | -17.2881355932 | 2.95 | 2.9517 | 2.1511 | 182523 | 2.48964526 | CS |
12 | 0.06 | 2.52100840336 | 2.38 | 3.6 | 2.1511 | 277153 | 2.83455753 | CS |
26 | -1.86 | -43.2558139535 | 4.3 | 4.39 | 2.08 | 292133 | 2.98343858 | CS |
52 | -1.98 | -44.7963800905 | 4.42 | 5.09 | 1.8101 | 376334 | 3.13944913 | CS |
156 | -13.52 | -84.7117794486 | 15.96 | 16.5 | 1.8101 | 416088 | 6.47577247 | CS |
260 | -22.63 | -90.2672516953 | 25.07 | 26.98 | 1.8101 | 403173 | 6.92241044 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.